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infiltration with ropivacaine after breast cancer











Background: The effect of local infiltration after breast surgery is controversial. This prospective double blind
randomized study sought to document the analgesic effect of local anaesthetic infiltration after breast cancer
surgery.
Methods: Patients scheduled for mastectomy or tumorectomy and axillary nodes dissection had immediate
postoperative infiltration of the surgical wound with 20 ml of ropivacaine 7.5 mg.ml
-1 or isotonic saline. Pain was
assessed on a visual analogue scale at H2, H4, H6, H12, H24, H72, and at 2 month, at rest and on mobilization of
the arm. Patient’comfort was evaluated with numerical 0-3 scales for fatigue, quality of sleep, state of mood, social
function and activity.
Results: Twenty-two and 24 patients were included in the ropivacaine and saline groups respectively.
Postoperative pain was lower at rest and on mobilization at 2, 4 and 6 hour after surgery in the ropivacaine group.
No other difference in pain intensity and patient ‘comfort scoring was documented during the first 3 postoperative
days. Patients did not differ at 2 month for pain and comfort scores.
Conclusion: Single shot infiltration with ropivacaine transiently improves postoperative pain control after breast
cancer surgery.
Trial registration number: NCT01404377
Background
Surgical wound infiltration with a local anaesthetic solu-
tion is currently performed in many surgical procedures
including, abdominal hysterectomy, caesarean section
and inguinal hernia repair [1]. Wound infiltration is
reported to provide immediate postoperative pain con-
trol lasting for several hours [2]. In addition, long term
benefits have been suggested such as prevention of
chronic pain syndrome after surgery [1]. Breast cancer
surgery is associated with mild to moderate pain but
some procedures including axillary nodes dissection are
more painful [3]. In these patients, pain may impair
postoperative comfort and may prevent from mobiliza-
tion of the corresponding upper limb. Moreover, studies
have pointed out that chronic pain syndromes may
develop after breast surgery that could be, at least partly,
related to the intensity of acute postoperative pain and
axillary nodes dissection [4]. Local infiltration with a
local anaesthetic solution, has been studied on several
instances with disappointing results, most of the studies
documenting indeed the lack of significant effect of
wound infiltration on postoperative pain after breast
surgery [5]. Several flaws and methodological bias may
question the results of these studies. For example, lido-
caine, that is a very short acting anaesthetic agent, is
used in most of the clinical trials [5]. In addition, in sev-
eral trials breast infiltration is not combined with axil-
lary infiltration [5]. Moreover, less painful procedures
such as tumorectomy are mixed up with more painful
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any medium, provided the original work is properly cited.ones. Petttersson et al. have indeed suggested that local
infiltration is worth performing only in patients sub-
mitted to the most painful procedures [6]. Eventually,
pain is measured at rest and not on movements which
are considered more painful. These many reasons justify
a well conducted prospective study aiming to assess the
analgesic effect of a long lasting local anaesthetic used
for complete infiltration of the surgical incisions.
Methods
This prospective, double-blind, randomized, single cen-
tre study was approved by an institutional ethical com-
mittee (Comité Consultatif de Protection des Personnes
dans la Recherche Biomédicale Paris- Cochin, president:
P r .G u e r i nC ,a p p r o v a lo nO c t o b e r1 1
th 2005, registra-
tion number 2277) and written informed consent of the
patients was obtained. ASA I - II patients, older than 18
years, scheduled for unilateral mastectomy or tumorect-
omy associated with axillary nodes dissection were
included in the study. Patients receiving opioid or any
other analgesic treatment for chronic pain before sur-
gery, patients with known allergy to local anaesthetics,
and patients with acquired or genetic haemostatic
abnormality were excluded.
On the morning of surgery, patients were allocated
randomly into two groups, using a table of random
numbers and already prepared sealed envelopes. In the
treated group infiltration was performed with a ropiva-
caine 7.5 mg.ml-1 solution and in the control group
with an isotonic saline solution. Solutions were prepared
and provided by the anaeshetist in charge of the patient
in the operating theatre, to the surgeon blinded for
patient allocation. In the two groups patients were oper-
ated under general anaesthesia using propofol 2.5 mg.
kg-1 and sufentanil 0.25 mcg.kg-1 for induction, and
sevoflurane 1-1.5% and nitrous oxide 50% in oxygen for
maintenance. Atracurium 0.6 mg.kg-1 was used for oro-
tracheal intubation. Dexamethasone 4 mg was given
intravenously after anaesthetic induction for prevention
of postoperative nausea and vomiting. Twenty milliliters
of the allocated solution were used, at the end of the
surgical procedure, shared in two equal parts, to infil-
trate the subcutaneous and deep layers of the breast and
axilla surgical incisions. Infiltration was performed
under direct vision by the surgeon. On awakening from
anaesthesia, immediately at the end of surgery, patients
were placed in a recovery room. Postoperatively, in case
of pain, patients were instructed to use tablets of para-
cetamol 1g every 6 hours for 3 days. If pain was not
controlled by paracetamol 5 mg of subcutaneous mor-
phine were used as a rescue.
Pain intensity was measured on a visual analogue scale
graded from 0 to 100. Measurements were recorded by
nurses blinded for patient allocation, for pain at rest,
and on maximum abduction of the operated arm
(patients were asked to perform abduction of the arm as
far as they could and pain intensity corresponding to
this movement, was recorded). Pain measurements were
performed at 2, 4, 6, 12, 24, 48, and 72 hour after the
end of surgery. The value of maximum abduction angle
was noted for each patient.
To evaluate quality of life patients were asked to score
on a 4 points scale graded from 0 (the worst) to 3 (the
best) the following items: sleep - fatigue - global activity
- relationship with relatives - state of mood. A global
score was attributed to each patient as the sum of cate-
gorical scores. Evaluation was performed at 24, 48 and
72 hour after the end of surgery.
Patients left the hospital between the fourth and the
sixth postoperative day. They were evaluated at two
month, during the postoperative surgical consultation,
for residual pain at rest and on movement using a visual
analogue scale and for quality of life as previously
defined.
T h es a m p l es i z ew a sb a s e do na ne s t i m a t eo fa3 0 %
(SD 10%) decrease in pain intensity on mobilization on
the day of surgery that was considered as the primary
outcome. Given a type I error of 0.05 and a Type II
error of 0.1, the required sample size was 22 patients
per group; 25 patients were included in each group to
take into account possible dropouts. Secondary out-
comes were a decrease in pain score at rest, a decrease
in rescue analgesic consumption and an improvement in
the quality of life.
Statistical analyses were performed with Stata v10.0
software (Stata Corporation, College Station, TX,
USA).”. Results are expressed as mean+/- standard
deviation (SD). Normally distributed data (VAS scores,
abduction angles) were analyzed using a two-way analy-
sis of variance. Categorical data (surgical procedure,
operative side, adjuvant chemotherapy) were analyzed
using Chi-2 test or Fisher’se x a c tt e s t .M a n n - W h i t n e y
U-test was used for comparison of age, BMI, weight,
and duration of surgery. P < 0.05 was considered
significant.
Results
Three patients in the ropivacaine group and one in the
control group were dropped out for surgical complica-
tion (one patient) and early discharge from hospital pre-
venting from complete data collection (3 patients).
Patients were comparable for demographics except for
mean age which was statistically higher in the ropiva-
caine group (table 1). Types of surgical procedures and
duration of surgery were comparable in the two groups.
Measurement of pain on visual analogue scale documen-
ted lower scores at rest and on mobilization, in the ropi-
vacaine group, 2, 4 and 6 hours after the end of the
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not significant afterward. Paracetamol consumption over
the first three postoperative days was 5.7+/-3.4 g and
6.9+/-3.6 g in the ropivacaine and the control groups
respectively. Two patients in the control group and 3 in
the ropivacaine group received a 5 mg subcutaneous
dose of morphine rescue medication. Values of arm
abduction angle were comparable in the two groups at
each time of measurement (Figure 3). Five patients in
the ropivacaine group and 4 patients in the control
group had nausea or vomiting. Mean score values for
quality of sleep and for global assessment of quality of
life were also comparable (Tables 2 &3). Five patients in
each group complained of postoperative nausea.
Two months after surgery VAS scores at rest were 4.4
+/-10.7 and 9.1+/-15.2 in the control and the ropivacaine
groups respectively (NS). Values of VAS scores on mobi-
lization were 21.4+/-4.1 and 20.2+/-4.0 in the control
and the ropivacaine groups respectively. Arm abduction
angles were 147+/-23° and 139+/-29° in the control and
the ropivacaine groups respectively. At this time, the
quality of sleep was comparable in the two groups (2.9
+/-.3 and 2.7+/-.6 in the control and the ropivacaine
groups respectively) and the groups did not differ for glo-
bal evaluation of quality of life (13.0+/-.2 and 12.3+/-.4 in
the control and the ropivacaine groups respectively)
Discussion
This study documents significant but short duration ben-
efit of wound infiltration after cancer breast surgery with
axillary nodes clearance. Infiltration with ropivacaine
solution was nevertheless effective for 6 hours after sur-
gery but pain was controlled as well in patients without
infiltration after this period of time. Since incomplete
evaluation of pain and its consequences, were considered
as flaws in previous studies, we carefully monitored pain,






Age (yr) 50 ± 11 58 ± 13*
Weight (kg) 67 ± 14 69 ± 11
BMI 25 ± 5 26 ± 5
Operative side (R/L) 13/11 10/12
Duration of surgery (min) 83 ± 25 126 ± 152
Mastectomy/Tumorectomy + axillary nodes dissection 17/7 17/5
Adjuvant chemotherapy (Y/N) 5/19 3/19




















Figure 1 VAS scores on mobilization of the arm on the operated side in the two groups of patients in the postoperative period and
at two month. * P < 0.05.
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Page 3 of 6not only at rest but also on mobilization. We performed
measurements of pain intensity soon after surgery, to
evaluate the initial effect of infiltration. We assessed
abduction of the upper limb knowing that it could be
more painful after axillary incision, and we also evaluated
patient’s comfort. Nevertheless, local infiltration did not
improve the ability to move the operated arm. Eventually,
patient’s comfort was equally effective when patients had
been infiltrated or not.
The duration of the effect of ropivacaine infiltration
was in fact comparable to that reported by Baudry et al
[7]. and to the effect documented in other surgical pro-
cedures such as hernia repair [2]. Using a shorter acting
local anaesthetic agent, i.e. lidocaine, Rosaeg et al docu-
mented a significant effect during less than 4 hours after
non cancer breast surgery [8]. This has led others to use
continuous wound infiltration after radical mastectomy


















Figure 2 VAS scores at rest in the two groups of patients in the postoperative period and at two month. * p < 0.05.

















Figure 3 Values of abduction angle of the arm in the postoperative period and at two month in the control and the ropivacaine
groups.
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is not always worth performing due to a rapid decrease
in pain intensity as observed in the current study. We
observed indeed that due to paracetamol administration,
pain was comparably controlled in postoperative
patients after 12 hours, even when they had not received
ropivacaine infiltration. Paracetamol is a weak non
opioid analgesic and the fact that pain was controlled by
paracetamol administration supports the hypothesis that
pain intensity was mild to moderate but not severe
enough to the point of requiring additional analgesic
technique during the first days after surgery. In other
words, analgesia was easily achieved with paracetamol in
most of the patients making the combination with con-
tinuous wound infiltration useless. In agreement only a
few patients required rescue morphine in the two
groups. A significant improvement in surgical technique
over the past years, that makes it less invasive, traumatic
and consequently less painful, may account for this mat-
ter of fact.
We looked at parameters that could be impaired by
pain in the postoperative period. The incidence of nau-
sea was comparable and quite low in the two groups
thanks to the preoperative administration of dexametha-
sone. In addition, dexamethasone could also have con-
tributed to postoperative pain control as previously
documented [11]. Arm abduction angle that could be
limited by pain in the axilla, was in fact quite high in
both groups and increased comparably during the first
postoperative days. We also assess quality of postopera-
tive recovery through a composite index including fati-
gue, state of mood, activity, sleep, and relationship with
relatives and found it also comparable in the two groups
and only slightly altered. We especially report values of
sleep’s quality that was poorly disturbed in the post-
o p e r a t i v ep e r i o dl i k e l yd u e ,a sf o rt h ec u m u l a t i v es c o r e
of quality of life, to adequate pain control.
The balance between advantages and drawbacks of
local infiltration should consider the risk of adverse
events. Although not reported in this series, the risk of
inadvertent intravascular injection has to be kept in
mind, prevented by careful aspiration before injection.
Although it has been claimed that infiltration and
regional block may have long lasting effect and may pre-
vent the occurrence of late pain after surgery especially
after breast surgery [12], the results of this study do not
support this hypothesis. In studies from Fassoulaki et al.
regional anaesthetic technique was more complete,
including thoracic nerve block and was also associated
with adjuvant treatment [12,13]. Baudry et al. have
looked for chronic pain after cancer breast surgery by
telephone interview one year after surgery, and failed to
document a decreased incidence in patients who had
received local infiltration of the operative wound [7].
Thus, the direct preventive effect of local infiltration on
late pain after surgery remains to be demonstrated.
Several other studies have also documented that regio-
nal anaesthesia using thoracic paravertebral block pro-
vided better pain control after unilateral breast surgery
[14-17]. Most of the time surgical procedures were
more important including breast reconstruction. Para-
vertebral block ensures a complete anaesthesia of the
hemithoracic wall and the axilla that depends on T1
sensory distribution. Thoracic paravertebral block has
been compared to local infiltration and demonstrated to
be superior [9]. When indicated by a painful surgical
procedure, thoracic paravertebral is therefore a better
alternative than local wound infiltration for postopera-
tive pain control.
One can argue that preoperative infiltration, before
skin incision would had provide better results in terms
of postoperative pain control. Nevertheless, preoperative
wound infiltration has not been documented to be
superior to postoperative infiltration in the specific set-
ting of breast surgery [18]. This study has several limita-
tions. One can argue that the number of patients was
limited but it was calculated in agreement with the
main outcome and allows robust conclusion concerning
this outcome. Patient mean age was older in the ropiva-
caine group. Since increasing age may result in decreas-
ing pain scoring and in decreasing the incidence of
chronic pain after breast surgery, this difference, that
occurred by random, may have contributed at least
partly to the difference in pain scores [19]. The follow
up was limited to two months but no difference in pain
control was pointed out at this time making unlikely















1.9 ± 1.1 2.3 ± 0.8 2.6 ± 0.6 2.7 ± 0.6
Sleep is quoted on a 4 points scale from 0 (the worst) to 3 (the best
imaginable). Values are expressed as mean +/- standard deviation
Table 3 Score of quality of life after surgery.
12H 24H 48H 72H
Control group
(N = 24)
10.3+2.4 10.7+2.4 10.6+1.9 12.0+1.5
Ropivacaine group
(N = 22)
9.9+3.0 10.9+2.7 11.9+2.1 12.5+1.9
Postoperative fatigue, sleep, state of mood, relationship with relatives, and
global activity are quoted on a 4 points scale from 0 (the worst) to 3 (the best
imaginable). At each time of measurement the global score (maximum value:
15) is the addition of scores established for each parameter. Values are
expressed as mean +/- standard deviation
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was used but VAS scores during the first postoperative
days were adequately controlled as previously discussed.
Conclusion
In patients scheduled for cancer breast surgery with
axillary nodes dissection, wound infiltration with ropiva-
caine provides an effective pain control during a period
of time limited to the first hours following surgery. No
further benefit is documented then after.
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